Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Shares Slide 5.3 Percent Despite Asian Distribution Deal

NEW YORK, Dec. 2 (GenomeWeb News) - Shares in CombiMatrix were down 5.26 percent, or $.10, at $1.80 in mid-afternoon trading today despite word that the company has hired a distributor to market its products in Asia.

 

As GenomeWeb News reported today, Cell Sciences will distribute CombiMatrix's products and services in Singapore, Malaysia, Thailand, Philippines, Hong Kong, and Indonesia.

 

Under terms of the non-exclusive agreement, Cell Sciences, a subsidiary of the CyGenics Group, will market and sell CombiMatrix's CustomArrays and CatalogArrays, including its recently introduced Influenza Research Microarray in those markets.

 

Earlier this week, CombiMatrix said Cell Sciences would distribute its products and services only in Singapore.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.